Literature DB >> 2283199

Pulmonary hemorrhage following intravenous streptokinase for acute myocardial infarction.

L J Disler1, A Rosendorff.   

Abstract

A 50-year-old man was given 1.2 million units of intravenous streptokinase 3 hours after the onset of a hyperacute inferior myocardial infarction. He had been treated for pneumonia 4 weeks previously. Five days after thrombolytic therapy, he developed a massive hemoptysis. The implications of this side effect are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2283199     DOI: 10.1016/0167-5273(90)90132-o

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Sudden appearance of a mass on chest X-ray.

Authors:  D Ledrick; H Khalil; J Tita; V Mahajan
Journal:  Postgrad Med J       Date:  1998-04       Impact factor: 2.401

2.  Diffuse pulmonary hemorrhage after fibrinolytic therapy for acute myocardial infarction in a cocaine abuser patient.

Authors:  Mohammad Parsa Mahjoob; Isa Khaheshi; Koosha Paydary
Journal:  Heart Views       Date:  2014-07

3.  Fatal Hemoptysis during Coronary Thrombolysis.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

4.  Pulmonary haemorrhage following thrombolysis with streptokinase in myocardial infarction.

Authors:  Krishna Prasad; Parminder Singh; Kewal Kanabar; Rajesh Vijayvergiya
Journal:  BMJ Case Rep       Date:  2020-01-23

5.  Abnormal Chest X-ray Postmyocardial Infarction.

Authors:  Ahmed M Abuosa; Ayman H El-Sheikh; Abdulhalim Jamal Kinsara
Journal:  Heart Views       Date:  2014 Oct-Dec

6.  Pulmonary alveolar hemorrhage following thrombolytic therapy.

Authors:  Santhosh Narayanan; N K Thulaseedharan; Gomathy Subramaniam; Geetha Panarkandy; Narayanan Arathi
Journal:  Int Med Case Rep J       Date:  2017-04-04

7.  Pulmonary thromboembolism and alveolar hemorrhage as initial manifestations of systemic lupus erythematosus.

Authors:  O Jiménez-Zarazúa; L N Vélez-Ramírez; C A Ramírez-Casillas; J D Mondragón
Journal:  Lupus       Date:  2022-01-18       Impact factor: 2.911

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.